Augmedix Inc
NASDAQ:AUGX
Augmedix Inc
NASDAQ:AUGX
Price:
3.18 USD
-7.83%
Market Closed
Updated:
Apr 18, 2024
Augmedix Inc
Operating Income
Last
Value
3-Years CAGR
5-Years CAGR
|
Augmedix Inc
Operating Income Peer Comparison
Comparables:
VEEV
INSP
EVH
DOCS
CERT
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Augmedix Inc
NASDAQ:AUGX
|
Operating Income
$-18.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Operating Income
$429.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
27%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Operating Income
$-40.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Evolent Health Inc
NYSE:EVH
|
Operating Income
$12.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Operating Income
$125.1m
|
CAGR 3-Years
78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Certara Inc
NASDAQ:CERT
|
Operating Income
$6.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Augmedix Inc's Operating Income?
Operating Income
-18.8m
USD
-18.8m
USD
Based on the financial report for Dec 31, 2023, Augmedix Inc's Operating Income amounts to -18.8m USD.
What is Augmedix Inc's Operating Income growth rate?
Operating Income CAGR 5Y
4%
4%
Over the last year, the Operating Income growth was 16%. The average annual Operating Income growth rates for Augmedix Inc have been -11% over the past three years , 4% over the past five years .
You don't have any saved screeners yet
